Table 5.

Three-month change from baseline in hormones (ChbioT, ChE₂, and ChBioE₂) to change in blood characteristics (ChRBC, ChHCT, and ChHGB) correlation among TE treatment group

	ChRBC, Pearson Coefficient (P Value)	ChHCT, Pearson Coefficient (P Value)	ChHGB, Pearson Coefficient (P Value)
ChT	−0.043 (0.846); n = 25	0.125 (0.569); n = 24	0.110 (0.617); n = 24
ChBioT	0.109 (0.612); n = 24	0.253 (0.244); n = 23	0.063 (0.776); n = 23
ChDHT	0.057 (0.786); n = 25	0.183 (0.393); n = 24	0.091 (0.673); n = 24
ChE2	0.398 (0.049); n = 25	0.191 (0.372); n = 24	0.415 (0.044); n = 24
ChBioE2	0.339 (0.097); n = 25	0.227 (0.286); n = 24	0.388 (0.061); n = 24

T, testosterone; E₂, estradiol; BioE₂, bioavailable fractions of E₂; n = no. of observations.